Q&A with Claire Smith, Alternatives Directors, Private Assets
Q&A with Claire Smith, Alternatives Directors, Private Assets
Graeme Mather, Head of Distribution sat down with Claire Smith at our 2021 Market Outlook Event: Through the lens. Visit our events portal to watch the recording, download a copy of the speaker presentations, read content for your clients and more.
What do small to mid-cap private companies look like? Are we referring to mum and dad owners of small business?
Claire Smith: The average EBITDA is probably about 50 million so we define small to mid-cap as 50 to 100 million of EBITDA and the large cap as 500 million plus. So as you can see through things like WeWor,k that we're not invested in, companies can get very large and still remain private in the current environment.
With high prices everywhere, and enormous demand for private assets globally, is the team confident there's a sufficient pipeline of opportunities?
Claire Smith: As I've outlined, that large buyout segment is where perhaps there is too much capital chasing a limited number of deals. It's quite interesting if you analyse the returns of private equity funds, the larger the fund gets, the more homogenous their returns become. We are really trying to operate in that smaller segment where we think there is still opportunity to buy companies at good fundamental prices, and also add value. That's what we're trying to do in the private equity space, is take the company, make some operational improvements, or help them expand geographically, or vertically, and add on the value so that we can exit at a better price. So we do think there's value, you have to avoid the crowded part of the market and really focus on that smaller specialised part where we think there's good fundamentals and the opportunity to buy at good prices.
The number of publicly listed companies is reducing in the US and UK due to increases in regulation. Does this mean there is more opportunity in private equity?
Claire Smith: Yes, I think companies are taking longer to list, the private equity market has matured and they've got the luxury to remain private for longer. There's a general preference and a better alignment of interest between private ownership and privately held companies because you could set a five to 10 year strategic plan and you're not worried about distractions, such as reporting season right now that can take a lot of focus from implementing a multi-year strategic plan. Companies like tech and healthcare, where they might not need a lot of capital to begin with, prove to be a big opportunity. For example, just in healthcare, I think there's only 1000 listed healthcare companies but there's 150,000 privately held healthcare companies. We think there's parts of the market where it’s better to access through private equity rather than listed markets.
Are there any sectors in private markets that are more prevalent than listed markets?
Claire Smith: Across private assets you can invest in real estate, infrastructure, private equity but we are just focused in this particular strategy on privately held companies. 50% of what we do is within tech and healthcare and the other 50% is across consumer industrials and services. Tech was the origins of the companies and still one of our longest running and best performing strategies but we find, particularly healthcare in the current environment, is adding a lot of popularity and we're seeing a lot of opportunities there.
Do you have to sell a private company as soon as it lists?
Claire Smith: We do have a couple of companies that have IPO’d in our portfolio. We're holding for six months as the general rule and as soon as that period is expired, that's when we'll look to sell. We don't want to be holding listed companies in the portfolio because that's fundamentally not what we do. There is generally a holding period after IPO and then we'll look to liquidate as soon as that expired.
The RNB entry and play - is that China's mandate for investors or encouraging it?
Claire Smith: We have an investment team on the ground in China, locals who speak the language. In order to get that access to Renminbi we have a qualified foreign limited partner regime so we have to meet certain capital adequacy ratios but China has made it easier to invest. Previously you had to request currency when you'd identified the deal which is obviously quite challenging in private equity because you're on a tight timeframe. Now what the Chinese government has done is let you raise money for a blind pool of capital, so we can apply for 200 million that we want to invest in deals and we don't have to know specifically what those deals are. It's becoming easier, but there's still a lot of restrictions around capital, people on the ground, directors, so there's a lot of headwinds. We've spent about nine months setting up this program and it's going reasonably well so every quota we've asked for in general from Renminbi we've been given. They are making steps to make it easier, but it still requires a fair bit of overhead I would say.
The fund had an outstanding return last year - is that repeatable or have the best investment values been realised?
Claire Smith: In 2020 we were very lucky. It was pretty early in the portfolio and more concentrated than I think it will be when it becomes more mature so that opens up opportunity but also risk. We were very fortunate that a company that was 5% of the holding increased in value by five times which has driven the performance so I would say, a 40% return is not what we should expect every year. But as the portfolio matures, it will add more diversification. It was an exceptional year, I'd love to say it's going to be repeated every year, but I think 10-12% per annum is a more reasonable long run estimate for this type of strategy.
Is this fund available as a listed product? Do you see any risks/disadvantages in ASX listed products within this asset class?
Claire Smith: Traditional private equity funds are usually closed ended and your money is locked up for around 10, 12, or 14 years. What we've done is made it as liquid as possible while retaining the features of private equity - keeping the volatility out, keeping the valuations based on fundamentals. Our fund is not listed, it is an Australia's unitised trust so people can apply on a monthly basis, and they can apply to access capital on a quarterly basis. There are some caps on redemptions so if your personal circumstances change and you want your money back, it should be reasonably easy to access because the 5% is a global cap. This is a fund that's sold around the world, we have a feeder fund so there's already a couple of 100 million of AUM over the 12 months that its been operating. The thing to bear in mind as a risk is if there is a liquidity crunch and everyone wants their money back at the same time, that's when the cap can come into effect. It’s real private companies underlying the portfolio, the valuations do take about a month to produce because we are individually valuing every company within the portfolio because people are buying and selling at that price. The fund is available on wrap platforms, Hub24 and Netwealth, which really helps with the accessibility.
- What you need to know about equity markets in 2022
- 5 defensive allocation ideas for 2022
- MyStory: the firm tackling our plastic waste in Japan
- Schroders' Market Outlook 2022: Red light, green light
- Schroders' Market Outlook 2022: The essence of equities
- Schroders Equity Lens: your go-to guide to global equity markets
This material has been issued by Schroder Investment Management Australia Limited (ABN 22 000 443 274, AFSL 226473) (Schroders) for information purposes only. It is intended solely for professional investors and financial advisers and is not suitable for distribution to retail clients. The views and opinions contained herein are those of the authors as at the date of publication and are subject to change due to market and other conditions. Such views and opinions may not necessarily represent those expressed or reflected in other Schroders communications, strategies or funds. The information contained is general information only and does not take into account your objectives, financial situation or needs. Schroders does not give any warranty as to the accuracy, reliability or completeness of information which is contained in this material. Except insofar as liability under any statute cannot be excluded, Schroders and its directors, employees, consultants or any company in the Schroders Group do not accept any liability (whether arising in contract, in tort or negligence or otherwise) for any error or omission in this material or for any resulting loss or damage (whether direct, indirect, consequential or otherwise) suffered by the recipient of this material or any other person. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. Any references to securities, sectors, regions and/or countries are for illustrative purposes only. You should note that past performance is not a reliable indicator of future performance. Schroders may record and monitor telephone calls for security, training and compliance purposes.